The LYNX-3 Clinical Study is seeking participants aged 18 and older who have had LASIK or other corrective eye surgery but now struggle with poor night or dim light vision, including symptoms like glare, halos, or starbursts. This research evaluates an investigational once-daily eye drop medication over a two-week period, providing all study-related care and medication at no cost through three clinic visits. By participating, eligible individuals can help doctors develop new medical options for the millions of Americans currently living without an approved therapy for diminished night vision.
Clinical Study for Poor Night Vision After LASIK or Corrective Eye Surgery


